The cholesterol synthesis rate-limiting enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) was up-regulated in many tumors such as gastric cancer, glioma and prostate cancer. The gene discussed is HMGCR; the disease is prostate cancer.